HYBRID EVENT: You Can Participate In Person At Barcelona, Spain Or Virtually From Your Home Or Work
ICCTDR · Registering as Listener

International Conference on Clinical Trials in Diabetes Research

28–29 Dec 2026 Barcelona, Spain Standard / Physical Participation
Listener Registration
$135
virtual · $175 in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.
All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon code

Have a code? Apply it here — the discount updates the total immediately.
Apply

1. Policy on Cancellations & Refunds :

  • A full refund is possible only if the cancellation request is submitted at least 70 days before the conference, with formal paperwork completed at least 60 days prior.
  • If cancellation occurs between 60 and 30 days before the event, partial refunds may be granted based on administrative costs incurred.
  • Cancellations made within 30 days of the event are non-refundable, though participants will receive a credit valid for one year.
  • Registrations made less than 30 days before the event are not eligible for refunds, but may be transferred to another ISIT conference.
  • Since this conference is hybrid format, the organizer reserves the right to conduct the event either in-person or virtually. Please note that no refunds will be issued due to changes in the event format.
  • Virtual registration fees are non-refundable. A credit will instead be issued for use at a future conference event.

2. Participation & Registration Requirements :

  • To attend an ISIT event, participants must complete the registration process within the stipulated time.
  • The event schedule, venue, and format are subject to changes at the discretion of the organizers, with prior notice sent via email.
  • ISIT is not liable for any financial losses resulting from changes in event details.
  • Fees paid for registration are strictly non-refundable.
  • If the primary author cannot participate, a co-author may attend instead, but refunds will not be granted for non-attendance.

3. Submission & Publication Norms :

  • Researchers submitting papers to ISIT must ensure their institution or supervisor is aware of their submission.
  • Each submission is subject to a rigorous peer review before being accepted for presentation.
  • Only papers linked to a completed registration will be included in conference proceedings.
  • The submitting author is considered the primary author; ISIT does not verify individual authorship claims.
  • If any concerns regarding authorship arise and are validated, the paper will be withdrawn without reconsideration.
  • Once a paper is removed, it cannot be reintroduced into any ISIT publication.

4. Travel & Accommodation Responsibilities :

  • Attendees are responsible for making their own travel and lodging arrangements.
  • ISIT does not provide logistical assistance for travel or accommodation.
  • The organization bears no responsibility for expenses incurred due to conference modifications or rescheduling.

5. Visa & Invitation Letter Policy :

  • Attendees are responsible for making their own travel and lodging arrangements.
  • ISIT does not provide logistical assistance for travel or accommodation.
  • The organization bears no responsibility for expenses incurred due to conference modifications or rescheduling.
  • ISIT does not engage directly with consulates or embassies on behalf of attendees.
  • Participants must handle their own visa applications and processes.
  • Important Information Regarding Invitation Letters:
    • The invitation letter is provided solely for conference attendance and does not serve as a document for immigration, employment, or residency purposes.
    • The letter assists in visa applications but does not guarantee visa approval.
    • ISIT holds no responsibility for visa denials or processing delays, and all related costs are borne by the applicant.
    • Any alterations or unauthorized use of the invitation letter will result in its invalidation and possible cancellation of conference participation.
    • Legal action may be pursued if the document is misused.
    • By accepting the invitation letter, attendees agree to comply with international travel regulations and ethical participation standards.

6. Registration Transfers :

  • Registrations may be transferred to another individual from the same institution if the original participant cannot attend.
  • Transfer requests must be made via email to [email protected] with necessary details and supporting documents.
  • Transfers must be requested at least 14 days before the event; otherwise, they will not be accommodated.
  • Transferred registrations are not eligible for refunds.

7. General Considerations :

  • Any modifications or cancellations must be communicated in writing to [email protected].
  • Registration confirms acknowledgment and acceptance of these policies.
  • ISIT does not initiate automatic transactions; all payments are voluntarily completed by registrants.
  • Once registered, participants must submit a conference registration form within three days for confirmation.
  • Travel plans should only be finalized after receiving the official conference itinerary, which will be shared 15 days before the event.

8. Conference Programme and Participation Policy :

  • Presentations from different but relevant academic areas may be combined by the Organiser within an interdisciplinary or multidisciplinary programme to encourage cross-disciplinary understanding, interaction, and future research partnerships.
Payments encrypted & processed securely. Refundable up to 14 days before the event.

What you'll hear about

Session tracks covered across the event.
View all 11 tracks →
This track focuses on novel methodologies and frameworks for designing clinical trials specifically tailored to diabetes research. Emphasis will be placed on adaptive trial designs and real-world evidence integration.
This session will explore the latest pharmacological interventions for diabetes treatment, including new drug developments and combination therapies. Discussions will highlight efficacy, safety, and patient adherence.
This track will examine the role of lifestyle modifications in diabetes management, including diet, exercise, and behavioral therapy. Participants will discuss evidence-based strategies for effective patient engagement.
This session will delve into methodologies for assessing clinical outcomes in diabetes research, including quality of life and long-term health impacts. The importance of patient-reported outcomes will also be highlighted.
This track will address challenges and innovative solutions in recruiting and retaining participants for diabetes clinical trials. Best practices and case studies will be shared to enhance trial feasibility.
This session will focus on the identification and validation of biomarkers relevant to diabetes pathophysiology and treatment response. Discussions will include the implications of biomarker discovery for personalized medicine.
This track will explore the translation of basic research findings into clinical applications for diabetes management. Emphasis will be on bridging the gap between laboratory discoveries and patient care.
This session will provide insights into the regulatory landscape governing clinical trials in diabetes research. Participants will discuss compliance, ethical considerations, and the impact of regulations on trial design.
This track will highlight the role of technology in diabetes care, including digital health tools, wearable devices, and telemedicine. The impact of these innovations on clinical trial outcomes will be examined.
This session will focus on the design and implementation of longitudinal studies to track diabetes progression over time. The implications of such studies for understanding disease mechanisms and treatment efficacy will be discussed.
This track will examine the global landscape of diabetes clinical trials, including disparities in research and access to care. Participants will discuss collaborative efforts to enhance trial diversity and inclusivity.